RecruitingNCT02253030
OCT Angiography in Wet AMD
Optical Coherence Tomography Angiography in Neovascular Age-related Macular Degeneration
Sponsor
Oregon Health and Science University
Enrollment
160 participants
Start Date
Sep 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to: 1. diagnose the presence of new blood vessels in wet age-related macular degeneration (AMD) 2. evaluate patients undergoing treatment for wet AMD 3. determine if reduced flow to the choroid is a risk factor for developing wet AMD.
Eligibility
Min Age: 50 YearsMax Age: 100 Years
Inclusion Criteria5
- Adults aged 50 and older with clinical findings of treatment-naïve (never treated) neovascular AMD with active new blood vessel growth confirmed by clinical testing will be considered
- No evidence of retinal disease
- Refractive error greater than +3.00 diopters or -7.00 diopters (glasses Rx)
- No recent eye surgery in the last 4 months
- No significant cataract to interfere with the quality of the imaging
Exclusion Criteria6
- Inability to give informed consent
- Significant kidney disease
- Blood pressure greater than 180/110
- Previous macular laser treatment
- Inability to maintain stable fixation during OCT imaging
- Visual acuity worse than 20/200
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEOptical Coherence Tomography
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02253030